XML 143 R115.htm IDEA: XBRL DOCUMENT v3.22.0.1
EMPLOYEE STOCK BENEFIT PLANS - Summary of Stock Compensation Activity (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Weighted-average exercise price per stock      
Total intrinsic value of stock options exercised $ 512 $ 556 $ 148
Stock Options      
Stock compensation activity, shares      
Stock options, beginning balance (in shares) 73.4    
Stock options, granted (in shares) 0.0    
Stock options, released/exercised (in shares) (23.1)    
Stock options, adjustments for actual payout (in shares) 0.0    
Stock options, forfeited/canceled (in shares) (3.3)    
Stock options, ending balance (in shares) 47.0 73.4  
Weighted-average exercise price per stock      
Stock options, weighted-average exercise price at the beginning of the period (in dollars per share) $ 50.25    
Stock options, granted, weighted-average exercise price at the beginning of the period (in dollars per share) 0    
Stock options, released/exercised, weighted-average exercise price at the beginning of the period (in dollars per share) 42.70    
Stock options, adjustments for actual payout, weighted-average exercise price at the beginning of the period (in dollars per share) 0    
Stock options, forfeited/canceled, weighted-average exercise price at the beginning of the period (in dollars per share) 63.71    
Stock options, weighted-average exercise price at the end of the period (in dollars per share) 53.00 $ 50.25  
Other than options, granted, weighted average grant date fair value (in usd per share) $ 0 $ 0 $ 15.00
Options nonvested (in shares) 2.0    
Options nonvested, weighted average exercise price (in usd per share) $ 48.22    
Unrecognized compensation cost $ 7    
Expected weighted-average period in years of compensation cost to be recognized 7 months 6 days    
Restricted Stock Units      
Stock compensation activity, shares      
Other than options, beginning balance (in shares) 27.7    
Other than options, granted (in shares) 8.9    
Other than options, released/exercised (in shares) (13.8)    
Other than options, adjustments for actual payout (in shares) 0.0    
Other than options, forfeited/canceled (in shares) (3.7)    
Other than options, ending balance (in shares) 19.1 27.7  
Weighted-average exercise price per stock      
Other than options, weighted average grant date fair value at the beginning of the period (in usd per share) $ 54.58    
Other than options, granted, weighted average grant date fair value (in usd per share) 56.58 $ 53.65 $ 47.16
Other than options, released/exercised, weighted average grant date fair value (in usd per share) 55.36    
Other than options, adjustments for actual payout, weighted average grant date fair value (in usd per share) 0    
Other than options, forfeited/canceled, weighted average grant date fair value (in usd per share) 54.71    
Other than options, weighted average grant date fair value at the end of the period (in usd per share) $ 54.92 $ 54.58  
Other than options, expected to vest (in shares) 17.0    
Other than options, expected to vest, weighted average grant date fair value (in usd per share) $ 54.91    
Unrecognized compensation cost $ 676    
Expected weighted-average period in years of compensation cost to be recognized 2 years 7 months 6 days    
Fair value of awards that vested during the year $ 246 $ 122 $ 105
Restricted Stock Units | Legacy Celgene Plans      
Weighted-average exercise price per stock      
Other than options, granted, weighted average grant date fair value (in usd per share) $ 0 $ 0 $ 56.37
Fair value of awards that vested during the year $ 519 $ 777 $ 233
Market Share Units      
Stock compensation activity, shares      
Other than options, beginning balance (in shares) 1.7    
Other than options, granted (in shares) 1.0    
Other than options, released/exercised (in shares) (0.6)    
Other than options, adjustments for actual payout (in shares) 0.0    
Other than options, forfeited/canceled (in shares) (0.3)    
Other than options, ending balance (in shares) 1.8 1.7  
Weighted-average exercise price per stock      
Other than options, weighted average grant date fair value at the beginning of the period (in usd per share) $ 56.01    
Other than options, granted, weighted average grant date fair value (in usd per share) 58.04 $ 53.92 $ 51.52
Other than options, released/exercised, weighted average grant date fair value (in usd per share) 57.25    
Other than options, adjustments for actual payout, weighted average grant date fair value (in usd per share) 0    
Other than options, forfeited/canceled, weighted average grant date fair value (in usd per share) 56.15    
Other than options, weighted average grant date fair value at the end of the period (in usd per share) $ 56.51 $ 56.01  
Other than options, expected to vest (in shares) 1.6    
Other than options, expected to vest, weighted average grant date fair value (in usd per share) $ 56.51    
Unrecognized compensation cost $ 46    
Expected weighted-average period in years of compensation cost to be recognized 2 years 9 months 18 days    
Fair value of awards that vested during the year $ 37 $ 37 $ 30
Performance Share Units      
Stock compensation activity, shares      
Other than options, beginning balance (in shares) 3.1    
Other than options, granted (in shares) 1.5    
Other than options, released/exercised (in shares) (0.9)    
Other than options, adjustments for actual payout (in shares) 0.1    
Other than options, forfeited/canceled (in shares) (0.4)    
Other than options, ending balance (in shares) 3.4 3.1  
Weighted-average exercise price per stock      
Other than options, weighted average grant date fair value at the beginning of the period (in usd per share) $ 56.72    
Other than options, granted, weighted average grant date fair value (in usd per share) 59.04 $ 55.61 $ 49.99
Other than options, released/exercised, weighted average grant date fair value (in usd per share) 67.60    
Other than options, adjustments for actual payout, weighted average grant date fair value (in usd per share) 67.60    
Other than options, forfeited/canceled, weighted average grant date fair value (in usd per share) 56.04    
Other than options, weighted average grant date fair value at the end of the period (in usd per share) $ 55.38 $ 56.72  
Other than options, expected to vest (in shares) 3.2    
Other than options, expected to vest, weighted average grant date fair value (in usd per share) $ 54.85    
Unrecognized compensation cost $ 83    
Expected weighted-average period in years of compensation cost to be recognized 1 year 8 months 12 days    
Fair value of awards that vested during the year $ 61 $ 59 $ 53